To keep up-to-date with the latest in regulatory science, follow CIRS on LinkedIn.
For CIRS publications including R&D Briefings, journal articles and reports, please visit the Publications area.
Last week CIRS Head of Regulatory Collaborations and RAPS board member Dr Lawrence Liberti discussed "Challenges and Opportunities for Using Facilitated Regulatory Pathways (FRPs) in Mature and Emerging Markets" as [...]
We’re delighted to announce that we’ve been selected as a Technical Resource Partner for the Promoting the Quality of Medicines Plus (PQM+) programme, which is funded by the US Agency [...]
CIRS Awarded a Grant to Help Accelerate Registration of Medicines in Low and Middle Income Countries
We’re delighted that the Bill and Melinda Gates Foundation is continuing to support our work with medicine regulatory agencies in low- and middle-income countries (LMICs) through the OpERA programme. The [...]